Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Bliss Gvs Pharma Limited (BLISSGVS) Price & Analysis

BLISSGVS Stock Chart & Stats

₹648.40-₹34.10(-5.00%)
At close: 4:00 PM EDT
INR 500INR 600INR 7003 Aug17 Aug31 Aug15 Sep28 Sep12 Oct26 Oct
Day’s Range
INR 648.40 - INR 672.00
52-Week Range
INR 118.35 - INR 744.75
Previous Close
INR 682.50
Volume
571.01K
Average Volume (3M)
20.63K
Market Cap
INR 68.94B
Enterprise Value
INR 21.82B
Total Cash (Recent Filing)
INR 1.89B
Total Debt (Recent Filing)
INR 0
Price to Earnings (P/E)
50.7
Beta
1.03
Next Earnings
Jan 26, 2027
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
0.23%

Bulls Say, Bears Say

Bulls Say

Revenue And Earnings Growth

Sustained revenue expansion and stronger recent net income indicate improving commercial scale and earnings capacity. If this trajectory continues, Bliss GVS Pharma should have a broader base from which to support product development, market expansion, and operating resilience over the coming quarters.

Conservative Balance Sheet

Low and declining leverage gives the company financial flexibility and reduces the burden of interest and refinancing obligations. Rising equity and assets provide a stronger capital base to absorb earnings volatility and support continued investment without relying heavily on additional borrowing.

Improving Cash Generation

Strong recent operating and free cash flow improves the company’s ability to fund operations and strategic needs internally. The sharp free-cash-flow rebound also suggests recent earnings have translated more effectively into liquidity, strengthening financial flexibility over the next several quarters.

Bears Say

Volatile Profitability

Historical margin swings show that earnings power has not been consistently stable, even though the latest year improved. Such volatility can make future profit performance harder to forecast and may limit confidence that recent profitability will persist through changing operating conditions.

Unpredictable Cash Conversion

Uneven cash conversion means reported earnings may not consistently become available cash in each period. This variability can complicate funding plans, reduce confidence in the timing of internally generated resources, and make the company’s financial performance less predictable over a two-to-six-month horizon.

Operating-profitability Clarity

Limited margin detail and the unusual EBITDA-to-EBIT relationship make it harder to assess the durability and composition of reported operating profits. Reduced visibility into operating quality can weaken forecast confidence and complicate evaluation of whether recent earnings gains are repeatable.

Bliss Gvs Pharma Limited News

BLISSGVS FAQ

What was Bliss Gvs Pharma Limited’s price range in the past 12 months?
Bliss Gvs Pharma Limited lowest stock price was ₹118.35 and its highest was ₹744.75 in the past 12 months.
What is Bliss Gvs Pharma Limited’s market cap?
Bliss Gvs Pharma Limited’s market cap is ₹68.94B.
When is Bliss Gvs Pharma Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bliss Gvs Pharma Limited’s earnings last quarter?
Bliss Gvs Pharma Limited released its earnings results on Aug 12, 2026. The company reported ₹4.73 earnings per share for the quarter.
Is Bliss Gvs Pharma Limited overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Bliss Gvs Pharma Limited pay dividends?
Bliss Gvs Pharma Limited pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.23%. See more information on Bliss Gvs Pharma Limited dividends here
What is Bliss Gvs Pharma Limited’s EPS estimate?
Bliss Gvs Pharma Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bliss Gvs Pharma Limited have?
Bliss Gvs Pharma Limited has 106,330,475 shares outstanding.
What happened to Bliss Gvs Pharma Limited’s price movement after its last earnings report?
Bliss Gvs Pharma Limited reported an EPS of ₹4.73 in its last earnings report. Following the earnings report the stock price went up 4.992%.
Which hedge fund is a major shareholder of Bliss Gvs Pharma Limited?
Currently, no hedge funds are holding shares in IN:BLISSGVS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology